Duloxetine for the Treatment of Chronic Pelvic Pain
Status:
Terminated
Trial end date:
2015-11-04
Target enrollment:
Participant gender:
Summary
This study is examining the effectiveness of duloxetine as a treatment for chronic pelvic
pain in women. Duloxetine is FDA approved for the treatment of other pain conditions,
including fibromyalgia and diabetic neuropathy.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore